CLDX logo

Celldex Therapeutics, Inc. (CLDX) Depreciation and amortization

annual D&A:

$3.18M+$169.00K(+5.62%)
December 31, 2024

Summary

  • As of today (September 19, 2025), CLDX annual depreciation & amortization is $3.18 million, with the most recent change of +$169.00 thousand (+5.62%) on December 31, 2024.
  • During the last 3 years, CLDX annual D&A has risen by +$109.00 thousand (+3.55%).
  • CLDX annual D&A is now -45.79% below its all-time high of $5.86 million, reached on December 31, 2010.

Performance

CLDX Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

quarterly D&A:

$873.00K+$6000.00(+0.69%)
June 1, 2025

Summary

  • As of today (September 19, 2025), CLDX quarterly depreciation & amortization is $873.00 thousand, with the most recent change of +$6000.00 (+0.69%) on June 1, 2025.
  • Over the past year, CLDX quarterly D&A has increased by +$76.00 thousand (+9.54%).
  • CLDX quarterly D&A is now -64.04% below its all-time high of $2.43 million, reached on March 31, 2010.

Performance

CLDX quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

TTM D&A:

$3.35M+$76.00K(+2.32%)
June 1, 2025

Summary

  • As of today (September 19, 2025), CLDX TTM depreciation & amortization is $3.35 million, with the most recent change of +$76.00 thousand (+2.32%) on June 1, 2025.
  • Over the past year, CLDX TTM D&A has increased by +$247.00 thousand (+7.97%).
  • CLDX TTM D&A is now -45.51% below its all-time high of $6.14 million, reached on September 30, 2010.

Performance

CLDX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

CLDX Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.6%+9.5%+8.0%
3 y3 years+3.5%+17.8%+8.6%
5 y5 years-34.6%-23.9%-28.3%

CLDX Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+9.7%at high+30.1%at high+19.0%
5 y5-year-34.6%+9.7%-23.9%+30.1%-28.3%+19.0%
alltimeall time-45.8%+798.0%-64.0%+910.4%-45.5%+3245.0%

CLDX Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$873.00K(+0.7%)
$3.35M(+2.3%)
Mar 2025
-
$867.00K(+5.9%)
$3.27M(+2.9%)
Dec 2024
$3.18M(+5.6%)
$819.00K(+4.2%)
$3.18M(+1.9%)
Sep 2024
-
$786.00K(-1.4%)
$3.12M(+0.6%)
Jun 2024
-
$797.00K(+2.8%)
$3.10M(+1.3%)
Mar 2024
-
$775.00K(+2.1%)
$3.06M(+1.6%)
Dec 2023
$3.01M(+3.9%)
$759.00K(-1.0%)
$3.01M(+2.9%)
Sep 2023
-
$767.00K(+1.5%)
$2.92M(+3.4%)
Jun 2023
-
$756.00K(+4.1%)
$2.83M(+0.5%)
Mar 2023
-
$726.00K(+7.9%)
$2.81M(-2.9%)
Dec 2022
$2.90M(-5.6%)
$673.00K(+0.3%)
$2.90M(-3.5%)
Sep 2022
-
$671.00K(-9.4%)
$3.00M(-2.6%)
Jun 2022
-
$741.00K(-8.6%)
$3.08M(-0.7%)
Mar 2022
-
$811.00K(+4.4%)
$3.10M(+1.2%)
Dec 2021
$3.07M(-21.9%)
$777.00K(+3.3%)
$3.07M(+0.7%)
Sep 2021
-
$752.00K(-1.6%)
$3.05M(-3.5%)
Jun 2021
-
$764.00K(-1.4%)
$3.15M(-10.9%)
Mar 2021
-
$775.00K(+2.6%)
$3.54M(-9.9%)
Dec 2020
$3.93M(-19.1%)
$755.00K(-12.3%)
$3.93M(-9.0%)
Sep 2020
-
$861.00K(-25.0%)
$4.32M(-7.4%)
Jun 2020
-
$1.15M(-1.5%)
$4.67M(-0.1%)
Mar 2020
-
$1.17M(+1.7%)
$4.67M(-3.8%)
Dec 2019
$4.86M(+27.8%)
$1.15M(-5.2%)
$4.86M(+9.6%)
Sep 2019
-
$1.21M(+4.8%)
$4.43M(+9.2%)
Jun 2019
-
$1.15M(-14.7%)
$4.06M(+4.1%)
Mar 2019
-
$1.35M(+87.5%)
$3.90M(+2.6%)
Dec 2018
$3.80M(-28.4%)
$721.00K(-13.7%)
$3.80M(-12.1%)
Sep 2018
-
$835.00K(-15.9%)
$4.33M(-8.7%)
Jun 2018
-
$993.00K(-20.7%)
$4.74M(-4.7%)
Mar 2018
-
$1.25M(+0.5%)
$4.97M(-6.4%)
Dec 2017
$5.31M(+29.8%)
$1.25M(-0.2%)
$5.31M(+0.9%)
Sep 2017
-
$1.25M(+2.0%)
$5.26M(+5.9%)
Jun 2017
-
$1.23M(-23.0%)
$4.97M(+6.0%)
Mar 2017
-
$1.59M(+32.8%)
$4.69M(+14.5%)
Dec 2016
$4.09M(+2.0%)
$1.20M(+25.5%)
$4.09M(+2.4%)
Sep 2016
-
$954.00K(+0.8%)
$4.00M(-1.6%)
Jun 2016
-
$946.00K(-4.9%)
$4.06M(-0.5%)
Mar 2016
-
$995.00K(-9.5%)
$4.08M(+1.7%)
Dec 2015
$4.01M(+17.9%)
$1.10M(+7.8%)
$4.01M(+5.9%)
Sep 2015
-
$1.02M(+5.6%)
$3.79M(+4.5%)
Jun 2015
-
$966.00K(+4.4%)
$3.62M(+3.7%)
Mar 2015
-
$925.00K(+5.5%)
$3.49M(+2.7%)
Dec 2014
$3.40M(+15.5%)
$877.00K(+2.5%)
$3.40M(+3.5%)
Sep 2014
-
$856.00K(+2.4%)
$3.29M(+3.9%)
Jun 2014
-
$836.00K(+0.5%)
$3.16M(+3.5%)
Mar 2014
-
$832.00K(+9.0%)
$3.06M(+3.8%)
Dec 2013
$2.94M(-6.1%)
$763.00K(+4.2%)
$2.94M(+1.3%)
Sep 2013
-
$732.00K(+0.4%)
$2.91M(-0.8%)
Jun 2013
-
$729.00K(+1.1%)
$2.93M(-3.0%)
Mar 2013
-
$721.00K(-0.6%)
$3.02M(-3.6%)
Dec 2012
$3.14M(-24.6%)
$725.00K(-4.1%)
$3.14M(-3.6%)
Sep 2012
-
$756.00K(-7.9%)
$3.25M(-12.5%)
Jun 2012
-
$821.00K(-1.7%)
$3.72M(-5.8%)
Mar 2012
-
$835.00K(-0.9%)
$3.95M(-5.0%)
Dec 2011
$4.16M(-29.0%)
$843.00K(-31.0%)
$4.16M(-3.9%)
Sep 2011
-
$1.22M(+16.3%)
$4.33M(+3.8%)
Jun 2011
-
$1.05M(+0.6%)
$4.17M(-6.9%)
Mar 2011
-
$1.04M(+3.2%)
$4.48M(-23.6%)
Dec 2010
$5.86M(+65.9%)
$1.01M(-4.6%)
$5.86M(-4.5%)
Sep 2010
-
$1.06M(-21.8%)
$6.14M(+6.0%)
Jun 2010
-
$1.36M(-44.1%)
$5.79M(+11.8%)
Mar 2010
-
$2.43M(+88.1%)
$5.18M(+46.6%)
Dec 2009
$3.53M(+39.2%)
$1.29M(+80.8%)
$3.53M(+28.4%)
Sep 2009
-
$714.00K(-4.3%)
$2.75M(-3.5%)
Jun 2009
-
$746.10K(-4.5%)
$2.85M(-2.3%)
Mar 2009
-
$780.90K(+53.1%)
$2.92M(+14.9%)
Dec 2008
$2.54M(-5.6%)
$509.90K(-37.3%)
$2.54M(-37.9%)
Sep 2008
-
$813.40K(+0.2%)
$4.08M(+17.9%)
Jun 2008
-
$812.10K(+102.0%)
$3.46M(+20.2%)
Mar 2008
-
$402.00K(-80.4%)
$2.88M(+7.2%)
Dec 2007
$2.69M
$2.06M(+963.5%)
$2.69M(+120.0%)
DateAnnualQuarterlyTTM
Sep 2007
-
$193.30K(-15.7%)
$1.22M(-22.2%)
Jun 2007
-
$229.20K(+9.6%)
$1.57M(-14.2%)
Mar 2007
-
$209.10K(-64.6%)
$1.83M(-12.6%)
Dec 2006
$2.10M(+31.7%)
$590.00K(+8.8%)
$2.10M(+7.2%)
Sep 2006
-
$542.30K(+10.6%)
$1.95M(+4.7%)
Jun 2006
-
$490.20K(+3.6%)
$1.87M(+8.4%)
Mar 2006
-
$473.10K(+5.4%)
$1.72M(+8.2%)
Dec 2005
$1.59M(+14.7%)
$449.00K(-1.4%)
$1.59M(+7.1%)
Sep 2005
-
$455.40K(+32.0%)
$1.49M(+19.9%)
Jun 2005
-
$344.90K(+0.7%)
$1.24M(-10.1%)
Mar 2005
-
$342.40K(-0.2%)
$1.38M(-0.7%)
Dec 2004
$1.39M(-1.7%)
$343.00K(+64.0%)
$1.39M(+19.3%)
Sep 2004
-
$209.10K(-56.7%)
$1.16M(-14.3%)
Jun 2004
-
$483.40K(+37.1%)
$1.36M(+2.1%)
Mar 2004
-
$352.70K(+198.4%)
$1.33M(-5.8%)
Dec 2003
$1.41M(-13.0%)
$118.20K(-70.7%)
$1.41M(-16.4%)
Sep 2003
-
$403.80K(-11.2%)
$1.69M(+0.4%)
Jun 2003
-
$454.90K(+4.6%)
$1.68M(+3.3%)
Mar 2003
-
$435.10K(+10.2%)
$1.63M(+0.4%)
Dec 2002
$1.62M(-28.1%)
$394.80K(-0.5%)
$1.62M(-11.4%)
Sep 2002
-
$396.90K(-1.0%)
$1.83M(-7.4%)
Jun 2002
-
$401.10K(-6.6%)
$1.98M(-7.8%)
Mar 2002
-
$429.30K(-28.8%)
$2.14M(-5.1%)
Dec 2001
$2.26M(+72.2%)
$603.00K(+11.2%)
$2.26M(+10.4%)
Sep 2001
-
$542.20K(-4.5%)
$2.05M(+13.5%)
Jun 2001
-
$567.70K(+4.3%)
$1.80M(+17.6%)
Mar 2001
-
$544.40K(+39.2%)
$1.53M(+16.9%)
Dec 2000
$1.31M(-34.1%)
$391.00K(+31.0%)
$1.31M(+7.8%)
Sep 2000
-
$298.50K(-0.1%)
$1.22M(-18.2%)
Jun 2000
-
$298.70K(-7.4%)
$1.49M(-15.0%)
Mar 2000
-
$322.60K(+9.1%)
$1.75M(-12.1%)
Dec 1999
$1.99M(+100.9%)
$295.70K(-48.0%)
$1.99M(-11.8%)
Sep 1999
-
$568.20K(+1.4%)
$2.25M(+16.3%)
Jun 1999
-
$560.60K(-0.6%)
$1.94M(+32.0%)
Mar 1999
-
$564.10K(+0.6%)
$1.47M(+48.3%)
Dec 1998
$989.80K(+179.8%)
$561.00K(+123.1%)
$989.80K(+87.2%)
Sep 1998
-
$251.50K(+176.7%)
$528.80K(+40.2%)
Jun 1998
-
$90.90K(+5.2%)
$377.30K(-2.4%)
Mar 1998
-
$86.40K(-13.6%)
$386.40K(-3.4%)
Dec 1997
$353.80K(-23.9%)
$100.00K(0.0%)
$400.00K(0.0%)
Sep 1997
-
$100.00K(0.0%)
$400.00K(-20.0%)
Jun 1997
-
$100.00K(0.0%)
$500.00K(0.0%)
Mar 1997
-
$100.00K(0.0%)
$500.00K(0.0%)
Dec 1996
$464.80K(-35.4%)
$100.00K(-50.0%)
$500.00K(-28.6%)
Sep 1996
-
$200.00K(+100.0%)
$700.00K(+16.7%)
Jun 1996
-
$100.00K(0.0%)
$600.00K(0.0%)
Mar 1996
-
$100.00K(-66.7%)
$600.00K(-14.3%)
Dec 1995
$719.60K(-14.8%)
$300.00K(+200.0%)
$700.00K(+16.7%)
Sep 1995
-
$100.00K(0.0%)
$600.00K(-14.3%)
Jun 1995
-
$100.00K(-50.0%)
$700.00K(-12.5%)
Mar 1995
-
$200.00K(0.0%)
$800.00K(0.0%)
Dec 1994
$844.70K(-6.1%)
$200.00K(0.0%)
$800.00K(-20.0%)
Sep 1994
-
$200.00K(0.0%)
$1.00M(0.0%)
Jun 1994
-
$200.00K(0.0%)
$1.00M(+11.1%)
Mar 1994
-
$200.00K(-50.0%)
$900.00K(0.0%)
Dec 1993
$900.00K(+50.0%)
$400.00K(+100.0%)
$900.00K(+80.0%)
Sep 1993
-
$200.00K(+100.0%)
$500.00K(-16.7%)
Jun 1993
-
$100.00K(-50.0%)
$600.00K(0.0%)
Mar 1993
-
$200.00K(-33.3%)
$600.00K(-14.3%)
Dec 1992
$600.00K(0.0%)
-
-
Oct 1992
-
$300.00K(+200.0%)
$700.00K(+16.7%)
Jul 1992
-
$100.00K(-50.0%)
$600.00K(0.0%)
Apr 1992
-
$200.00K(+100.0%)
$600.00K(0.0%)
Apr 1992
$600.00K(0.0%)
-
-
Jan 1992
-
$100.00K(-50.0%)
$600.00K(0.0%)
Oct 1991
-
$200.00K(+100.0%)
$600.00K(0.0%)
Jul 1991
-
$100.00K(-50.0%)
$600.00K(0.0%)
Apr 1991
$600.00K(+20.0%)
$200.00K(+100.0%)
$600.00K(+50.0%)
Jan 1991
-
$100.00K(-50.0%)
$400.00K(+33.3%)
Oct 1990
-
$200.00K(+100.0%)
$300.00K(+200.0%)
Jul 1990
-
$100.00K
$100.00K
Apr 1990
$500.00K
-
-

FAQ

  • What is Celldex Therapeutics, Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. annual D&A year-on-year change?
  • What is Celldex Therapeutics, Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. quarterly D&A year-on-year change?
  • What is Celldex Therapeutics, Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. TTM D&A year-on-year change?

What is Celldex Therapeutics, Inc. annual depreciation & amortization?

The current annual D&A of CLDX is $3.18M

What is the all time high annual D&A for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high annual depreciation & amortization is $5.86M

What is Celldex Therapeutics, Inc. annual D&A year-on-year change?

Over the past year, CLDX annual depreciation & amortization has changed by +$169.00K (+5.62%)

What is Celldex Therapeutics, Inc. quarterly depreciation & amortization?

The current quarterly D&A of CLDX is $873.00K

What is the all time high quarterly D&A for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high quarterly depreciation & amortization is $2.43M

What is Celldex Therapeutics, Inc. quarterly D&A year-on-year change?

Over the past year, CLDX quarterly depreciation & amortization has changed by +$76.00K (+9.54%)

What is Celldex Therapeutics, Inc. TTM depreciation & amortization?

The current TTM D&A of CLDX is $3.35M

What is the all time high TTM D&A for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high TTM depreciation & amortization is $6.14M

What is Celldex Therapeutics, Inc. TTM D&A year-on-year change?

Over the past year, CLDX TTM depreciation & amortization has changed by +$247.00K (+7.97%)
On this page